ArticleFrontiers in cardiovascular medicine2025
The burden of atherosclerotic cardiovascular disease among working-age people across SDI regions: an age-period-cohort study based on the GBD 2021.
Article in Frontiers in cardiovascular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Analysis of the Relationship Between Glycated Hemoglobin and Echocardiographic Parameters in Patients Without Diabetes: A Retrospective Study.Journal of clinical medicine · 2025Article
- Ischemic Heart Disease and the Epidemiologic Transition: Progress without Reduction in Global Burden.Discoveries (Craiova, Romania)Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Atherosclerotic cardiovascular disease (ASCVD) remains a leading health threat to the working-age population globally, with marked disparities in incidence and mortality across countries at different levels of socio-demographic development. Methods: Based on data from the Global Burden of Disease Study 2021, we used an age-period-cohort (APC) model to evaluate trends in the incidence and mortality of three major ASCVD subtypes-ischemic heart disease (IHD), ischemic stroke (IS), and peripheral artery disease (PAD)-among working-age adults (15-64 years) from 1992 to 2021 across five socio-demographic index (SDI) regions. The model further explored the contributions of age, period, and cohort effects. Results: Although age-standardized incidence and mortality rates of ASCVD have declined in most high-SDI regions and globally, the absolute number of cases and deaths has continued to rise, especially in middle- and low-SDI regions. Notably, PAD showed increasing incidence trends in several developing regions, suggesting persistent gaps in public awareness and preventive efforts. Conclusion: ASCVD remains a significant global public health challenge among the working-age population. SDI-specific and accessible interventions, along with strengthened cross-sector collaboration, are urgently needed to promote effective prevention and control of ASCVD worldwide.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.